Recently, Hefei Leecan Pharmaceutical received the drug registration certificate issued by the National    Medical Products Administration, officially approving the marketing of its acetylcysteine solution for inhalation (Drug Approval No. H20266343). This product marks the first drug approved by Hefei Leecan Pharmaceutical, signifying the entry of the Hefei production base into a new phase of commercial manufacturing and adding another significant milestone to Leecan Pharmaceutical's strategic development in the high-end inhaled drug formulation sector.

(Official Website of the National Medical Products Administration, October 22, 2026 - Drug Approval Document Delivery Information Screenshot)

Acetylcysteine solution for inhalation is a commonly used expectorant drug in clinical practice. It acts directly on the airway through nebulization and can lyse mucin in sputum, reduce sputum viscosity, and help patients expel phlegm. It is widely used in clinical scenarios such as respiratory infections and chronic airway diseases.

The approval of this product is the strongest recognition of Hefei Leecan Pharmaceutical's research and development, production, quality capabilities and level. The implementation of this product further consolidates the technological accumulation and industrialization capabilities of the pharmaceutical industry in the high-end inhalation field, enriches the product matrix in the respiratory field, and provides a safe and reliable new choice of domestic drugs for patients. And fully activate the industrialization capability of the Hefei base, connect the entire chain from research and development to commercialization, and lay a solid foundation for the subsequent landing and transformation of more high-end complex and innovative formulation products.

Based on the new starting point approved this time, Leecan Pharmaceutical will continue to focus on unmet clinical needs, seize the opportunity, continue to innovate, protect the health of billions of people with more high-quality drugs, and practice the corporate mission of "technology enhances the quality of life" with practical actions, helping the Chinese pharmaceutical industry accelerate the realization of higher quality development!